Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.57) per share. This is a 26.67 percent decrease over losses of $(0.45) per share from the same period last year.
BMO Capital Maintains Market Perform on Wajax, Lowers Price Target to C$23
BMO Capital analyst Devin Dodge maintains Wajax (TSX:WJX) with a Market Perform and lowers the price target from C$25 to C$23.